Cargando…

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG

The cannabinoid CB(2) receptor, which is activated by the endocannabinoid 2-arachidonoyl-glycerol (2-AG), protects striatal neurons from apoptotic death caused by the local administration of malonate, a rat model of Huntington's disease (HD). In the present study, we investigated whether endoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Valdeolivas, S, Pazos, M R, Bisogno, T, Piscitelli, F, Iannotti, F A, Allarà, M, Sagredo, O, Di Marzo, V, Fernández-Ruiz, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920947/
https://www.ncbi.nlm.nih.gov/pubmed/24136226
http://dx.doi.org/10.1038/cddis.2013.387
_version_ 1782303247923412992
author Valdeolivas, S
Pazos, M R
Bisogno, T
Piscitelli, F
Iannotti, F A
Allarà, M
Sagredo, O
Di Marzo, V
Fernández-Ruiz, J
author_facet Valdeolivas, S
Pazos, M R
Bisogno, T
Piscitelli, F
Iannotti, F A
Allarà, M
Sagredo, O
Di Marzo, V
Fernández-Ruiz, J
author_sort Valdeolivas, S
collection PubMed
description The cannabinoid CB(2) receptor, which is activated by the endocannabinoid 2-arachidonoyl-glycerol (2-AG), protects striatal neurons from apoptotic death caused by the local administration of malonate, a rat model of Huntington's disease (HD). In the present study, we investigated whether endocannabinoids provide tonic neuroprotection in this HD model, by examining the effect of O-3841, an inhibitor of diacylglycerol lipases, the enzymes that catalyse 2-AG biosynthesis, and JZL184 or OMDM169, two inhibitors of 2-AG inactivation by monoacylglycerol lipase (MAGL). The inhibitors were injected in rats with the striatum lesioned with malonate, and several biochemical and morphological parameters were measured in this brain area. Similar experiments were also conducted in vitro in cultured M-213 cells, which have the phenotypic characteristics of striatal neurons. O-3841 produced a significant reduction in the striatal levels of 2-AG in animals lesioned with malonate. However, surprisingly, the inhibitor attenuated malonate-induced GABA and BDNF deficiencies and the reduction in Nissl staining, as well as the increase in GFAP immunostaining. In contrast, JZL184 exacerbated malonate-induced striatal damage. Cyclooxygenase-2 (COX-2) was induced in the striatum 24 h after the lesion simultaneously with other pro-inflammatory responses. The COX-2-derived 2-AG metabolite, prostaglandin E(2) glyceryl ester (PGE(2)-G), exacerbated neurotoxicity, and this effect was antagonized by the blockade of PGE(2)-G action with AGN220675. In M-213 cells exposed to malonate, in which COX-2 was also upregulated, JZL184 worsened neurotoxicity, and this effect was attenuated by the COX-2 inhibitor celecoxib or AGN220675. OMDM169 also worsened neurotoxicity and produced measurable levels of PGE(2)-G. In conclusion, the inhibition of 2-AG biosynthesis is neuroprotective in rats lesioned with malonate, possibly through the counteraction of the formation of pro-neuroinflammatory PGE(2)-G, formed from COX-2-mediated oxygenation of 2-AG. Accordingly, MAGL inhibition or the administration of PGE(2)-G aggravates the malonate toxicity.
format Online
Article
Text
id pubmed-3920947
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-39209472014-02-13 The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG Valdeolivas, S Pazos, M R Bisogno, T Piscitelli, F Iannotti, F A Allarà, M Sagredo, O Di Marzo, V Fernández-Ruiz, J Cell Death Dis Original Article The cannabinoid CB(2) receptor, which is activated by the endocannabinoid 2-arachidonoyl-glycerol (2-AG), protects striatal neurons from apoptotic death caused by the local administration of malonate, a rat model of Huntington's disease (HD). In the present study, we investigated whether endocannabinoids provide tonic neuroprotection in this HD model, by examining the effect of O-3841, an inhibitor of diacylglycerol lipases, the enzymes that catalyse 2-AG biosynthesis, and JZL184 or OMDM169, two inhibitors of 2-AG inactivation by monoacylglycerol lipase (MAGL). The inhibitors were injected in rats with the striatum lesioned with malonate, and several biochemical and morphological parameters were measured in this brain area. Similar experiments were also conducted in vitro in cultured M-213 cells, which have the phenotypic characteristics of striatal neurons. O-3841 produced a significant reduction in the striatal levels of 2-AG in animals lesioned with malonate. However, surprisingly, the inhibitor attenuated malonate-induced GABA and BDNF deficiencies and the reduction in Nissl staining, as well as the increase in GFAP immunostaining. In contrast, JZL184 exacerbated malonate-induced striatal damage. Cyclooxygenase-2 (COX-2) was induced in the striatum 24 h after the lesion simultaneously with other pro-inflammatory responses. The COX-2-derived 2-AG metabolite, prostaglandin E(2) glyceryl ester (PGE(2)-G), exacerbated neurotoxicity, and this effect was antagonized by the blockade of PGE(2)-G action with AGN220675. In M-213 cells exposed to malonate, in which COX-2 was also upregulated, JZL184 worsened neurotoxicity, and this effect was attenuated by the COX-2 inhibitor celecoxib or AGN220675. OMDM169 also worsened neurotoxicity and produced measurable levels of PGE(2)-G. In conclusion, the inhibition of 2-AG biosynthesis is neuroprotective in rats lesioned with malonate, possibly through the counteraction of the formation of pro-neuroinflammatory PGE(2)-G, formed from COX-2-mediated oxygenation of 2-AG. Accordingly, MAGL inhibition or the administration of PGE(2)-G aggravates the malonate toxicity. Nature Publishing Group 2013-10 2013-10-17 /pmc/articles/PMC3920947/ /pubmed/24136226 http://dx.doi.org/10.1038/cddis.2013.387 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Valdeolivas, S
Pazos, M R
Bisogno, T
Piscitelli, F
Iannotti, F A
Allarà, M
Sagredo, O
Di Marzo, V
Fernández-Ruiz, J
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title_full The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title_fullStr The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title_full_unstemmed The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title_short The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG
title_sort inhibition of 2-arachidonoyl-glycerol (2-ag) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-ag
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920947/
https://www.ncbi.nlm.nih.gov/pubmed/24136226
http://dx.doi.org/10.1038/cddis.2013.387
work_keys_str_mv AT valdeolivass theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT pazosmr theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT bisognot theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT piscitellif theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT iannottifa theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT allaram theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT sagredoo theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT dimarzov theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT fernandezruizj theinhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT valdeolivass inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT pazosmr inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT bisognot inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT piscitellif inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT iannottifa inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT allaram inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT sagredoo inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT dimarzov inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag
AT fernandezruizj inhibitionof2arachidonoylglycerol2agbiosynthesisratherthanenhancingstriataldamageprotectsstriatalneuronsfrommalonateinduceddeathapotentialroleofcyclooxygenase2dependentmetabolismof2ag